Raffaella Origa

5.9k total citations · 2 hit papers
78 papers, 3.6k citations indexed

About

Raffaella Origa is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Raffaella Origa has authored 78 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 59 papers in Hematology and 26 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Raffaella Origa's work include Hemoglobinopathies and Related Disorders (70 papers), Iron Metabolism and Disorders (46 papers) and Blood groups and transfusion (16 papers). Raffaella Origa is often cited by papers focused on Hemoglobinopathies and Related Disorders (70 papers), Iron Metabolism and Disorders (46 papers) and Blood groups and transfusion (16 papers). Raffaella Origa collaborates with scholars based in Italy, United States and United Kingdom. Raffaella Origa's co-authors include Renzo Galanello, Gian Luca Forni, R. Galanello, Maria Domenica Cappellini, Antonio Piga, N. Giagu, Liliana Maccioni, Elizabeta Nemeth, Tomas Ganz and Gavino Faa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Raffaella Origa

74 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beta-thalassemia

2010 1.0k citations Renzo Galanello, Raffaella Origa profile →
β-Thalassemia

2016 308 citations Raffaella Origa profile →

Peers

Countries citing papers authored by Raffaella Origa

Since Specialization

Citations

This map shows the geographic impact of Raffaella Origa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaella Origa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaella Origa more than expected).

Fields of papers citing papers by Raffaella Origa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaella Origa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaella Origa. The network helps show where Raffaella Origa may publish in the future.

Co-authorship network of co-authors of Raffaella Origa

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaella Origa. A scholar is included among the top collaborators of Raffaella Origa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaella Origa. Raffaella Origa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice 2025 ·Journal of Clinical Medicine ·Valeria Maria Pinto, (unknown), Rosario Di Maggio, (unknown), (unknown), Filomena Longo, (unknown), Donatella Venturelli, Elena Cassinerio, Maddalena Casale, Raffaella Origa, Giovanni Zanconato, Gian Luca Forni, Lucia De Franceschi	0
2	Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study 2024 ·Annals of Hematology ·Khaled M. Musallam, Susanna Barella, Raffaella Origa, Giovanni Battista Ferrero, Roberto Lisi, (unknown), Filomena Longo, Barbara Gianesin, Gian Luca Forni, (unknown)	6
3	Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years 2024 ·Blood Cells Molecules and Diseases ·Khaled M. Musallam, Susanna Barella, Raffaella Origa, Giovanni Battista Ferrero, Roberto Lisi, (unknown), Filomena Longo, Barbara Gianesin, Gian Luca Forni	5
4	SCD MED ALERT, a Novel mHealth for Acute Pain Management, Contributes to the Empowerment of Patients with Sickle Cell Disease 2024 ·Blood ·(unknown), Barbara Gianesin, (unknown), Silverio Perrotta, (unknown), (unknown), Roberto Pirrone, (unknown), Valeria Maria Pinto, Michaela Calvillo, Raffaella Origa, Gian Luca Forni, Lucia De Franceschi	0
5	Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing 2024 ·Journal of Clinical Medicine ·Raffaella Origa, (unknown)	0
6	Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia 2023 ·Blood ·Khaled M. Musallam, Susanna Barella, Raffaella Origa, Giovanni Battista Ferrero, Roberto Lisi, (unknown), Filomena Longo, Barbara Gianesin, Gian Luca Forni	11
7	Management of the Sickle Cell Trait: An Opinion by Expert Panel Members 2023 ·Journal of Clinical Medicine ·Valeria Maria Pinto, Lucia De Franceschi, Barbara Gianesin, (unknown), Giovanna Graziadei, Letizia Lombardini, Giovanni Palazzi, (unknown), Rodolfo Russo, Laura Sainati, Donatella Venturelli, Gian Luca Forni, Raffaella Origa	6
8	Nephrological Complications in Hemoglobinopathies: SITE Good Practice 2023 ·Journal of Clinical Medicine ·(unknown), Rodolfo Russo, Tommaso Casini, Letizia Lombardini, (unknown), (unknown), Raffaella Origa, Gian Luca Forni, Monia Marchetti, (unknown), Giacomo Garibotto, Aurelio Maggio, Lucia De Franceschi	1
9	Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 2023 ·Journal of Clinical Medicine ·Filomena Longo, Irene Motta, Valeria Maria Pinto, (unknown), Paolo Ricchi, Immacolata Tartaglione, Raffaella Origa	5
10	Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending 2023 ·Pathogens ·Raffaella Origa	2
11	Le principali complicanze endocrinologiche nelle emoglobinopatie: buone pratiche cliniche della Società Italiana Talassemie ed Emoglobinopatie (SITE)* 2022 ·Recenti Progressi in Medicina ·Maddalena Casale, Marina Baldini, Patrizia Del Monte, (unknown), Anna Grandone, Raffaella Origa, Maurizio Poggi, Franco Gadda, (unknown), Monia Marchetti, Gian Luca Forni	1
12	Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 2022 ·Blood ·Valeria Maria Pinto, Khaled M. Musallam, Giorgio Derchi, Giovanna Graziadei, (unknown), Raffaella Origa, Susanna Barella, Gavino Casu, (unknown), Filomena Longo, Maddalena Casale, (unknown), Pierluigi Merella, Immacolata Tartaglione, Antonio Piga, Maria Domenica Cappellini, Barbara Gianesin, Gian Luca Forni, (unknown)	10
13	Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 2021 ·HemaSphere ·D Baronciani, Maddalena Casale, Lucia De Franceschi, Giovanna Graziadei, Filomena Longo, Raffaella Origa, Paolo Rigano, Valeria Maria Pinto, Monia Marchetti, (unknown), Achille Iolascon, Gian Luca Forni, (unknown)	6
14	Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 2020 ·Experimental Hematology and Oncology ·Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, Michael Pfeilstöcker, (unknown), Susanne Crowe, (unknown), Bruno Vincenzi, (unknown)	9
15	Treatment of hepatitis C virus infection with direct‐acting antiviral drugs is safe and effective in patients with hemoglobinopathies 2017 ·American Journal of Hematology ·Raffaella Origa, (unknown), Aldo Filosa, Alfonso Galeota Lanza, Antonio Piga, Giorgio Maria Saracco, Valeria Maria Pinto, A. Picciotto, Paolo Rigano, Salvatore Madonia, Rosamaria Rosso, Domenico Giuseppe D’Ascola, Maria Domenica Cappellini, Roberta D’Ambrosio, Immacolata Tartaglione, Lucia De Franceschi, Barbara Gianesin, V. Di Marco, Gian Luca Forni, (unknown)	32
16	Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up 2014 ·Parkinsonism & Related Disorders ·Giovanni Cossu, Giovanni Abbruzzese, Gildo Matta, Daniela Murgia, Maurizio Melis, Valeria Ricchi, Renzo Galanello, Susanna Barella, Raffaella Origa, Manuela Balocco, Elisa Pelosin, Roberta Marchese, (unknown), Gian Luca Forni	71
17	α-Globin Gene Quadruplication and Heterozygous β-Thalassemia: A Not So Rare Cause of Thalassemia Intermedia 2013 ·Acta Haematologica ·Raffaella Origa, Maria Carla Sollaino, Caterina Borgna‐Pignatti, Antonio Piga, Aurora Feliú Torres, (unknown), Renzo Galanello	8
18	Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen 2008 ·The Journal of Clinical Pharmacology ·Renzo Galanello, Antonio Piga, Maria Domenica Cappellini, Gian Luca Forni, (unknown), Raffaella Origa, Catherine Dutreix, Rossella Belleli, J. Ford, Gilles‐Jacques Rivière, (unknown), Daniele Alberti, Romain Séchaud	34
19	Onset of cardiac iron loading in pediatric patients with thalassemia major 2008 ·Haematologica ·John C. Wood, Raffaella Origa, Annalisa Agus, Gildo Matta, Thomas D. Coates, R. Galanello	81
20	Osteoporosis in β‐Thalassemia: Clinical and Genetic Aspects 2005 ·Annals of the New York Academy of Sciences ·Raffaella Origa, Elisa Fiumana, Maria Rita Gamberini, (unknown), Monica Mottes, Antonella Sangalli, E. Paglietti, R. Galanello, Caterina Borgna‐Pignatti	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact